Hydride-rhodium(III)-N-heterocyclic carbene catalysts for vinyl-selective H/D exchange: a structure-activity study by Giuseppe, Andrea di et al.
 1
Hydride-Rhodium(III)-N-Heterocyclic Carbene Catalysts for Vinyl-Selective H/D 
Exchange: A Structure-Activity Study 
Andrea Di Giuseppe,*[a] Ricardo Castarlenas,*[a,b] Jesús J. Pérez-Torrente,[a] Fernando J. Lahoz,[a] 
and Luis A. Oro*[a,c] 
Dedicated in memory of Prof. Dr. María Pilar García Clemente 
Abstract: A series of neutral and 
cationic RhIII-hydride and RhIII-ethyl 
complexes bearing a NHC ligand have been 
synthesized and evaluated as catalyst 
precursors for H/D exchange reaction of 
styrene using CD3OD as deuterium source. 
An array of varied ligands has been selected 
in order to understand how the 
stereoelectronic properties can modulate the 
catalytic activity. Most of these complexes 
resulted to be very active and selective in 
the vinylic-H/D exchange, without 
deuteration of the aromatic hydrogens, 
presenting very high selectivity toward the 
β-positions. In particular the cationic 
complex [RhClH(CH3CN)3(IPr)]CF3SO3 
showed an excellent catalytic activity 
reaching the maximum attainable degree of 
β-vinylic deuteration in only 20 min. 
Modulation of catalyst structure results in 
an improvement of the α/β selectivity. Thus, 
the [RhClH(κ2-O,N-C9H6NO)(SIPr)] 
catalyst, bearing a 8-quinolinolate ligand 
and an electron-donor and bulky NHC as 
SIPr, showed total selectivity for the β-
vinylic positions. This systematic study has 
shown that an increase in electron density 
and steric pressure on the metal center 
produces an improvement of catalytic 
activity and selectivity. Complexes bearing 
ligands with a very high steric hindrance 
resulted to be inactive. 
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Introduction 
Deuterium-labeled compounds are nowadays used as central 
tools in a wide range of fields, whether it be for fundamental 
research or practical applications, as for example, drug metabolism, 
structural study of biological macromolecules, reaction mechanisms 
and kinetics, quantification of environmental pollutants and residual 
pesticides, synthesis of heavy drugs, production of innovative 
optical materials or markers in diesel oil.[1] The straightforward 
H/D-exchange in the target molecule is a more efficient and cost 
effective preparative method than the classical multistep synthesis 
from deuterated starting materials.[2] However, the direct substrate 
deuteration generally requires harsh reaction conditions which 
constitutes a major drawback.[3] For this reason, the development of 
new catalysts with high activity and selectivity represents a very 
important challenging task.[2b] Transition metal based homogeneous 
and heterogeneous catalytic systems allow to carry out the H/D-
exchange reaction under mild conditions, preventing substrate 
decomposition, with high tolerance toward the main functional 
groups. Moreover, such catalytic systems open the way for the 
choice of the deuterium source, such as D2, D2O or organic 
deuterated solvents, in function of the most compatible conditions 
for the substrate.  
After the pioneer works by Garnett,[4] and Shilov[5] in the sixties, 
we have witnessed the development of a plethora of transition metal 
based homogeneous catalytic systems for H/D exchange, including 
iridium,[4c,6] rhodium,[4d,6g,t,7] palladium,[7h,8] platinum,[4a,b,5,7h,8a,c,9] 
ruthenium,[7i,10] cobalt,[11] and osmium.[7i,10h,12] The versatility of the 
organometallic catalysts is shown by their ability to deuterate 
different C-H groups from aliphatic,[2b,6k,m,7b,f,10b,e,i] aromatic, 
[2b,4a,6k,m,o,6s-u,7b,g,k,9d,10e,h,j,12]
 and vinylic substrates.[6a,n,7a,d,e,i,10g] 
However, the control of regio- and stereoselectivity still remains an 
important challenge, especially for the deuteration of olefins in the 
presence of aromatic groups. 
In this context, a key issue to take into account is that most of 
the transition metal-based catalytic systems proceed according to a 
C-H activation mechanism (Scheme 1a).[6,7f,g,k,8b,c,9d,10a-f,10h,12-13] The 
selectivity of the reaction depends on the activation energy of 
distinct C-H moieties, which is related to their dissociation energies, 
thus, the observed reactivity order of reaction is generally: Csp-
H>Csp2-H>Csp3-H. Particularly, in the case of substrates with both 
aromatic and olefinic groups, where the C-H bond dissociation 
energy is comparable, the selective activation of the vinylic protons 
is problematic.[14] An efficient strategy for the selective alkene 
deuterium-labeling consists in the use of metal-hydride species that 
proceed by an alternative insertion-elimination mechanism, which is 
not operative for aromatic protons (Scheme 1b).[4d,6g,7a,e,i,j,11] In 
addition, a high oxidation state of the metal center might reduce the 
competitive olefin C-H activation pathway and should prevent 
hydrogenation of the double bond of the target olefin. Moreover, a 
bulky powerful electron-donor ancillary ligand should provide 
additional stability to the hydride-metal species in high oxidation 
state while imparting an adequate steric pressure on the vicinity of 
the coordination site that can dramatically influence the reaction 
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selectivity. With this in mind, we envisage RhIII complexes[7d,i] 
bearing a N-heterocyclic carbene ligand (NHC)[15] as potential 
catalysts to carry out the H/D exchange of olefins in an active and 
selective manner. Thus, in this work we report the synthesis of a set 
of hydride-RhIII-NHC catalysts and the systematic study of their 
catalytic activity in deuterium labeling of styrene. The results of this 
study have allowed us to disclose highly efficient catalysts and to 
establish a relationship between the structure of the complex and its 
catalytic activity. A part of this work has been previously 
communicated.[7j]  
 
Scheme 1. Possible mechanism for H/D exchange reaction of olefins: C-H activation 
(top) and insertion/β-elimination pathway (bottom). 
Results and Discussion 
Synthesis of neutral hydride-RhIII-NHC complexes bearing a 
8-quinolinolate ligand. Dinuclear complexes of the type [Rh(µ-
Cl)(NHC)(η2-olefin)]2 are excellent starting materials since they are 
easy to prepare and very reactive.[16] With the aim of studying the 
effect of the NHC ligand on the catalytic activity we have prepared 
several catalytic precursors bearing a range NHC ligands having 
different steric hindrance and electron-donor ability:[17] 1,3-bis-(2,6-
diisopropylphenyl)imidazol-2-carbene (IPr), 1,3-bis-(2,6-
diisopropylphenyl)imidazolidin-2-carbene (SIPr), 2,4,6-
(trimethylphenyl)imidazol-2-carbene (IMes), 1,3-
dicyclohexylimidazol-2-carbene (ICy) and 2,6-
(dimethylphenyl)tetrahydropyrimidin-2-carbene (SPXyl), whose 
synthesis is reported in literature (Scheme 2).[18] 
 
Scheme 2. NHC ligands used in this work. 
The dinuclear [Rh(µ-Cl)(NHC)(η2-coe)]2 complexes were 
synthetized as described by James and coworkers.[16b] Thus, reaction 
of [Rh(µ-Cl)(η2-coe)2]2 (1) with the free NHC ligands gave the 
dinuclear complexes [Rh(µ-Cl)(IPr)(η2-coe)]2 (2a) and [Rh(µ-
Cl)(IMes)(η2-coe)]2 (3). Following the previously reported synthetic 
scheme,[7j] treatment of the dimers 2a and 3 with 8-
hydroxyquinoline in toluene at room temperature led to the 
diastereoselective synthesis of the 16-electron complexes 
[RhClH(κ2-O,N-C9H6NO)(NHC)] (4, IPr; 5, IMes) (Scheme 3). 
Complexes 4 and 5 were isolated as orange solids in 76%[7j] and 
79% yield, respectively. The synthesis of related mononuclear 
hydride/8-quinolinolate derivatives bearing carbenes SIPr and 
SPXyl was carried out following a one-pot procedure (Scheme 3). 
Thus, a mixture of [Rh(µ-Cl)(coe)2]2, 8-hydroxyquinoline and NHC 
(SIPr or SPXyl) was stirred at room temperature in THF for 2 h to 
give orange solutions of complexes [RhClH(κ2-O,N-
C9H6NO)(SIPr)] (6) and [RhClH(κ2-O,N-C9H6NO)(SPXyl)] (7), 
which were isolated as orange solids in good yields. Unfortunately, 
this synthetic approach did not work well for the ICy ligand. X-ray 
analysis of a crop of red crystals collected form the reaction mixture 
revealed the formation of the coordination ion-par [Rh(κ2-O,N-
C9H6NO)(ICy)3][RhCl2(κ2-O,N-C9H6NO)2]2. Most probably the 
formation of this species with three ICy ligands is a consequence of 
the lesser steric demand of the ICy ligand (Figure S1, Supporting 
Information). 
 
Scheme 3. Synthesis of neutral hydride-Rh-NHC 8-quinolinolate complexes 1-9.  
An X-ray diffraction structural analysis of complex [RhClH(κ2-
O,N-C9H6NO)(IPr)] (4) (Figure 1) substantiates the suggested strong 
trans influence of the hydride favoring the formation a square-
pyramidal structure with the hydride located in the apical position. 
The IPr ligand is located trans to the N-donor atom of the bidentate 
8-quinolinolate ligand (N(1)-Rh-C(10) = 171.92(9)°), with the 
chlorido ligand trans to the O-donor atom (Cl-Rh-O = 174.70(5)°)). 
The wingtips of the IPr adopt an out-of-plane disposition from the 
squarebase of the pyramid with the aromatic rings pointing to the 
vacant site and the hydride ligand. The rhodium-carbene separation 
(Rh-C(10) = 1.951(2) Å) agrees well with the expected value for a 
single Rh-C bond..[15c] 
 
Figure 1. Molecular diagram of 4. Selected bond lengths (Å) and angles (º): Rh-Cl 
2.2993(7), Rh-O 1.9965(19), Rh-N(1) 2.062(2), Rh-C(10) 1.951(2), Rh-H 1.43(4); Cl-
Rh-O 174.70(5), Cl-Rh-C(10) 91.24(7), Cl-Rh-N(1) 95.53(7), Cl-Rh-H 78(2), O-Rh-
N(1) 81.45(9), O-Rh-C(10) 92.13(8), O-Rh-H 107(2), N(1)-Rh-C(10) 171.92(9), N(1)-
Rh-H 109(2), C(10)-Rh-H 68(2). 
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The NMR analysis of complexes 5-7 showed a pattern of 
resonances comparable to that of complex 4 (for a resume of the 
most characteristic NMR data of complexes 4-16 see table S2 in 
supporting information). The most noticeable signals of the 1H-
NMR spectra of complexes 5, 6 and 7 at 298 K is a shielded doublet 
between δ -27.9 and -28.6 ppm (JRh-H = 44-47 Hz) corresponding to 
the hydride ligand. This high-field shifted signal and the large Rh-H 
coupling constant has also been observed in related rhodium-hydride 
complexes and is a diagnostic for a vacant site trans to hydride 
ligand.[7j, 19] Interestingly, complex 5 showed only one signal for the 
two imidazole protons of IMes at δ 6.39 ppm, which, in addition to 
three signals δ 2.47, 2.44, and 1.90 ppm for the eighteen methyl 
protons, indicates rapid rotation of the carbene ligand around the 
Rh-C axis at room temperature. A similar NMR-pattern was 
observed for 6, which is compatible with the fast rotation of the SIPr 
ligand around the Rh-C bond. However, the carbene ligand in 7 does 
not rotate as demonstrated by the presence of four signals for the 
four methyl groups of the SPXyl ligand (δ 2.64, 2.62, 2.56 and 2.55 
ppm). This is in accordance with the reduction of the C(carbene)-N-
C(phenyl) angle in the six-membered tetrahydropirimidine-type 
carbene, which produces the approaching of the phenyl substituents 
to the metal center hampering the rotation.[18b] A salient feature of 
the 13C{1H}-APT spectra of 5-7 is a deshielded doublet resonance 
corresponding to the Rh-CNHC carbon atom. This signal appears at δ 
177.5 ppm for complexes 5, bearing a carbene with a unsaturated 
imidazol skeleton, whereas it is shifted to 200.9 ppm and 208.2 ppm 
for complex 7 and 6, respectively, which suggested that these 
saturated carbenes are better electron donor ligands than the 
unsatured carbenes.[20]  
To get more information about the influence of the 8-
quinolinolate ligand on the catalytic activity, complexes containing 
an electron-poor analog, 5,7-dichloro-8-quinolinolate, or the bulkier 
ligand 2-methyl-8-quinolinolate were prepared. A synthetic route 
similar to that for 4 has been used in the synthesis of the 5,7-
dichloro-8-quinolinolate complex, [RhClH(κ2-O,N-
C9H4NOCl2)(IPr)] (8), which was obtained in 78% yield. On the 
other hand, the 2-methyl-8-quinolinol and 2a did not react at room 
temperature, probably because of the presence of the methyl group 
near of nitrogen that hinders the coordination to the metal. Thus, the 
reaction was carried out at 80°C for 2 hours to give [RhClH(κ2-O,N-
C9H5NOCH3)(IPr)] (9) in 72% isolated yield (Scheme 3). The 1H 
and 13C{1H} NMR spectra of 8 and 9 are in accordance with the 
proposed structure. In both cases the high-field shifted hydride 
resonance observed in the 1H-NMR signal at δ -27.81 ppm for 8 and 
-28.43 ppm for 9, and the large JRh-H are consistent with those of 
related unsaturated square-pyramidal complexes previously 
described. The different electronic structure of 8 with respect to 4 is 
reflected in the signals of the quinolinic ring, especially in the 13C 
NMR of the quaternary carbon atom directly bounded to the oxygen 
that is shifted from 170.9 ppm in 4 to 164.9 ppm in 8. In the case of 
the complex 9 no interaction between the methyl of the 2-methyl-8-
quinolinolate ligand and rhodium has been observed. 
Synthesis of cationic complexes containing the hydride-Rh-
IPr skeleton. Related cationic complexes containing the [RhH(IPr)] 
moiety have been synthesized in order to compare their catalytic 
properties with those of neutral complexes 4-9. Complex [RhH(κ2-
O,N-C9H6NO)(IPr)(CH3CN)2](PF6) (10) was prepared by removing 
the chlorido ligand in 4 by treatment with TlPF6 in acetonitrile 
(Scheme 4). Complex 10 was isolated as an orange solid in 68% 
yield. The 1H NMR spectrum of 10 in CD3CN showed the same 
pattern as [RhClH(κ2-O,N-C9H6NO)(IPr)(CH3CN)] (4-CH3CN) (the 
acetonitrile solvate of 4)[7j] with a hydride signal at δ -17.52 ppm 
(JRh-H of 21.1 Hz) and a downfield shifted signal at δ 7.54 ppm 
corresponding to the imidazole ring protons. These spectroscopic 
evidences strongly suggest that complex 10 in CH3CN solution is 
octahedral with a weakly coordinated acetonitrile ligand trans to the 
hydride ligand. In fact, both acetonitrile molecules exchange with 
the CD3CN solvent. The 13C{1H} spectrum displays a broad signal 
at δ 169.6 ppm corresponding to the carbene carbon atom. This 
value is upfield-shifted compared to that of complexes 4 or 4-
CH3CN (179.0 and 175.2 ppm respectively), probably due to the 
positive charge in the cationic complex 10. 
 
Scheme 4. Synthesis of complexes [RhH(κ2-O,N-C9H6NO)(IPr)(CH3CN)2]PF6 (10), 
[RhClH(CH3CN)3(IPr)]CF3SO3 (11), [RhCl2H(CH3CN)2(IPr)] (12) and 
[RhClH(CH3CN)4(IPr)](CF3SO3)2 (13). 
In order to assess the influence of 8-quinolinolate ligands on the 
catalytic activity of this type complexes, related hydride-RhIII-NHC 
where the bidentate ligand has been replaced by weakly bonded 
ligands such as acetonitrile were prepared. We synthesized 
complexes with a different number of chlorido ligands to obtain 
compounds with different charge (dicationic, monocationic and 
neutral) to better compare this new family of complexes with those 
previously described. In this case another source of hydride different 
from the 8-quinolinol has been used. One of the simplest species for 
hydride generation is a strong acid.[7a] We have selected two 
different acids to synthesize complexes with different charge: triflic 
acid (CF3SO3H) and hydrochloric acid. The former has been chosen 
for the relatively low coordination ability of the triflate anion, thus 
producing cationic RhIII-hydride derivatives after reaction with RhI 
complexes. In contrast, reaction with HCl should lead to neutral Cl-
RhIII-H complexes due to the simultaneous coordination of a 
chlorido ligand. Thus, two new complexes were prepared starting 
from dimer 2a and the corresponding acid in acetonitrile at low 
temperature: the cationic complex [RhClH(CH3CN)3(IPr)]CF3SO3 
(11) by addition of CF3SO3H, and the neutral 
[RhCl2H(CH3CN)2(IPr)] (12) by using HCl(aq) (Scheme 4). The 
preparation of a dicationic complex by treatment of complexes 11 or 
12 with AgPF6 or TlPF6 was unsuccessful. However, the addition of 
two equiv of CF3SO3H to an acetonitrile solution of the chlorido-
free dimer [Rh(µ-OH)(IPr)(η2-coe)]2 (2-OH) at -20°C, prepared 
recently in our laboratories,[21] lead to the formation of the dicationic 
complex [RhH(CH3CN)4(IPr)](CF3SO3)2 (13) in 91% isolated yield. 
The NMR spectra of 11-13 showed the typical pattern for a 
saturated RhIII complex with an octahedral geometry. In particular, 
the hydride ligand appears between δ -15.4 and -18.7 ppm with a 
very small JRh-H (7-8 Hz). Moreover, the signals of the imidazole 
protons in 11 and 13 also support this geometry since they are 
downfield shifted to 7.44 and 7.65 ppm. In the case of 12, the =CH 
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imidazole protons and carbons of the IPr ligand were found to be 
inequivalent and showed two resonances both in the 1H NMR (δ 
7.26 and 7.25 ppm) and in the 13C{1H} NMR spectrum (δ 126.7 and 
125.5 ppm). This spectroscopic evidence points to a freeze structure 
bearing a mirror plane which contains the imidazole plane, with a 
trans disposition of both chlorido ligands and discards a dinuclear 
structure (Scheme 4). Similarly to the behaviour observed for 10, all 
acetonitrile ligands exchange with the CD3CN solvent. The charge 
of the complexes seems to strongly influence the chemical shift of 
the IPr resonances, especially in the case of the carbene carbon atom. 
In fact, the increase in the charge involves a progressive shielding of 
this resonance: δ 167.0 ppm for the neutral complex 12, 161.2 ppm 
for the cationic species 11, and 153.8 ppm for the dicationic 13, 
which resulted to be the lowest chemical shift among all the 
prepared complexes of type H-RhIII-IPr. 
Synthesis of Et-RhIII-IPr complexes. Recently our research 
group reported the synthesis and characterization of a new RhI 
dinuclear complex [Rh(µ-Cl)(IPr)(η2-CH2=CH2)]2 (2b).[16e] In search 
for an alternative starting complex for the synthesis of RhIII 
derivatives we have studied the reactivity of the ethylene dimer 2b. 
Interestingly, treatment of 2b with 8-hydroxoquinoline or CF3SO3H 
resulted in the formation of Rh-ethyl compounds as a consequence 
of the insertion of the coordinated ethylene into the Rh-H bond of 
intermediate RhIII-hydride species.[7a,22] It is worthy of note that a 
similar reactivity was observed with styrene, although the insertion 
products could not be isolated in the solid state.[7j] However, the 
insertion of cyclooctene has never been observed in any of the Rh-H 
described complexes, probably because of the large size of this 
olefin. 
Reaction of [Rh(µ-Cl)(IPr)(η2-CH2=CH2)]2 (2b) with 8-
hydroxyquinoline in toluene gave an orange solution of the 
unsaturated complex [RhCl(CH2CH3)(κ2-O,N-C9H6NO)(IPr)] (14) 
which was isolated as an orange solid in 86% yield. Similarly to 
complex 4, the coordination of an acetonitrile molecule at the vacant 
site results in the formation of the 18 e- complex 
[RhCl(CH2CH3)(κ2-O,N-C9H6NO)(IPr)(CH3CN)] (15) (Scheme 5). 
 
Scheme 5. Synthesis of Rh-ethyl species 14 and 15. 
The spectroscopic properties of complex 14 closely resemble 
those of 4. The ethyl group does not seem to affect the rotation of 
the carbene moiety and at room temperature only one signal for the 
imidazole protons was observed at δ 6.71 ppm. As already stated, 
this upfield shifted signal points to a pentacoordinated structure. 
This consideration, together with the strong trans influence of the 
ethyl group, leads us to propose a square-pyramidal geometry tfor 
complex 14 with the ethyl in the apical position. As it could be 
expected, the methylene protons of the ethyl ligand are diasterotopic 
thus showing two doublet of doublet of quadruplets with a JRh-H of 
3.2 Hz. In the 13C{1H} NMR spectrum the carbene carbon atom 
appears as a doublet at δ 174.5 ppm with a JRh-C of 51.8 Hz, similar 
to the value observed for complex 4. The ethyl ligand was observed 
as a doublet at δ 21.0 ppm with a JRh-C of 28.4 Hz (>CH2) and a 
singlet at 20.6 ppm (CH3). The saturate complex 15 do not show 
remarkable differences in the NMR spectra compared to the 
unsaturated analog 14 apart from the deshielding of the proton 
signal of the imidazole at δ 7.32 ppm which is a diagnostic for an 
octahedral saturate RhIII-IPr complex. It is important to remark that, 
even in this case, at room temperature, the coordination of CH3CN 
does not prevent the free rotation of the carbene around the Rh-C 
bond. In addition, the coordination of an acetonitrile ligand trans to 
the ethyl ligand does not influence significantly the chemical shift of 
the >CH2 resonance in the 13C{1H} NMR spectrum (δ = 20.0 ppm, 
JRh-C = 28.5 Hz). 
The reaction of [Rh(µ-Cl)(IPr)(η2-CH2=CH2)]2 (2b) with 
CF3SO3H in CH3CN, did not afford the monocationic ethyl complex 
[RhCl(CH2CH3)(CH3CN)3(IPr)]+ analogous of 11. In fact, treating 
2b with 1 equiv of acid in CH3CN gave an equimolar mixture of 2b 
and the dicationic product [Rh(CH2CH3)(IPr)(CH3CN)4](CF3SO3)2 
(16). Treatment of this mixture with a second equiv of CF3SO3H 
gave a pale yellow solution of 16 which was isolated as a white 
solid in 79 % yield (Scheme 6). Surprisingly, treatment of the 
hydride species 11 with an excess of CF3SO3H does not result in the 
formation of the dicationic complex 13 (analogous to 16). It is 
therefore evident that the ethyl ligand provides a special 
stereoelectronic environment that increases the reactivity of the 
monocationic species. 
 
Scheme 6. Preparation of the dicationic complex 16. 
Singlecrystals of 16 suitable for X-ray analysis were obtained by 
slow diffusion of diethylether over a saturated solution of 16 in 
CH2Cl2 (Figure 2). The complex shows a slightly distorted 
octahedral geometry around the metal center with the IPr and ethyl 
ligands in cis disposition. The Rh-C(11) distance of 2.026(7) Å is 
typical of a single Rh-C bond.[15c] A similar distance can be 
observed between the Rh and the ethyl ligand (2.065(7) Å), with the 
methyl group pointing down from the IPr ligand with a torsion angle 
C(11)(IPr)-Rh-C1-C2 of 162.2(7)°. The two acetonitrile molecules 
oriented mutually trans exhibit a similar distance to the Rh center, 
Rh-N(1) 1.994(7)Å and Rh-N(3) 1.998(6)Å. However, the 
acetonitrile trans to the ethyl ligand has a longer Rh-N(2) separation 
of 2.197(7)Å which is in agreement with the high trans influence of 
the ethyl ligand. The acetonitrile trans to the IPr ligand shows an 
intermediate Rh-N bond distance of 2.092(7) Å. It is remarkable that 
the acetonitrile ligands cis to IPr are bonded in a bent fashion, 
presenting a deviation of about 14°, and angles of Rh-N(1)-C(3) 
165.5(6)°, Rh-N(2)-C(5) 166.3(6)° and Rh-N(3)-C(7) 166.9(7)°. 
Probably, this deviation results from the high steric pressure exerted 
by the carbene ligand in combination with the weakness of the 
rhodium-acetonitrile bonds. In fact, the acetonitrile disposed trans to 
the IPr ligand is also deviated, but by only 7.7° (Rh-N(4)-C(9) 
172.0(7)°). 
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Figure 2. Molecular diagram of the cation of 16. Selected bond lengths (Å) and 
angles (º): Rh-C(1) 2.065(7), Rh-N(1) 1.994(7), Rh-N(2) 2.197(7), Rh-N(3) 1.998(6), 
Rh-N(4) 2.092(7), Rh-C(11) 2.026(7); C(1)-Rh-N(1) 88.7(3), C(1)-Rh-N(2) 177.1(3), 
C(1)-Rh-N(3) 90.1(3), C(1)-Rh-N(4) 93.7(3), C(1)-Rh-C(11) 86.8(3), N(1)-Rh-N(2) 
92.9(3), N(1)-Rh-N(3) 168.0(2), N(1)-Rh-N(4) 82.6(3), N(1)-Rh-C(11) 96.3(3), N(2)-
Rh-N(3) 87.9(3), N(2)-Rh-N(4) 84.1(3), N(2)-Rh-C(11) 95.4(3), N(3)-Rh-N(4) 85.6(3), 
N(3)-Rh-C(11) 95.6(3), N(4)-Rh-C(11) 178.8(3). 
1H and 13C{1H} NMR spectra of 16 are in accordance with the 
proposed structure. In this case the symmetry of the complex, in 
combination with the rapid rotation of carbene, lead to only one 1H-
NMR signal for the four isopropyl protons and two signals for the 
eight methyl groups. The signal of the imidazole protons, as 
expected for a saturated hydride-RhIII-NHC- complex, appeared 
downfield shifted (δ 7.46 ppm) with respect to the analogue 
unsaturated complex. The >CH2 protons of the ethyl ligands display 
a single resonance at δ 2.76 ppm, which is in agreement with the Cs 
symmetry of the complex. Only one signal corresponding to free 
acetonitrile was observed due to fast exchange with the CD3CN 
solvent. The 13C{1H} NMR spectrum displays a doublet at δ 150.3 
ppm, with JRh-C = 52.2 Hz, corresponding to the carbene carbon 
atom, which is the most shielded within all complexes described in 
the work, probably due to the dicationic nature of the complex. The 
signal of methylene-carbon atom bonded to rhodium appears at δ 
18.4 ppm, similarly to that of 14 and 15, but the JRh-C of 17.6 Hz 
was significantly lower. 
Catalytic activity studies. The synthesized complexes have 
been evaluated as catalysts for H/D exchange in olefins using 
CD3OD as deuterium source. Styrene was chosen as a model olefin 
for the evaluation of catalytic activity and selectivity (Scheme 7). 
The reactions were performed in a NMR tube sealed under argon 
containing 0.5 mL of CD3OD with a 2 mol % of catalyst loading at 
25°C and was monitored by NMR spectroscopy. Vinylic deuteration 
was exclusively observed for all the catalysts with a very high 
selectivity towards β position (Figure 3, Table 1). 
 
Scheme 7. Selective H/D exchange reaction 
 
Figure 3. H/D exchange in styrene catalyzed by 4, 5, 6, 11, and 12. 
Table 1. Styrene H/D exchange promoted by different catalysts.[a] 
Entry Catalyst t[h] α-D[%][b] β-D[%][b] TOF1/2 [h-1][c] 
1 4 3 3 92 192 
2 5 5 8 92 178 
3 6 1 trace 92 306 
4 7 24[d] trace trace --- 
5 8 6 12 91 90 
6 9 7[d] 13 86 39 
7 10 24[d] 2 8 --- 
8 11 0.3 10 92 3110 
9 12 2.2 16 91 171 
10 13 24[d] trace trace --- 
11 14 4 6 92 139 
12 15 4 6 92 139 
13 16 24[d] trace trace --- 
[a] Reaction conditions: [Styrene] = 1M in 0.5 mL of CD3OD with 2 mol % of catalyst 
at 25°C. [b] % of deuterium incorporation at the determined position (α or β). [c] H/D 
exchange at β-position, TOF calculated at 50% of conversion. [d] Reaction performed at 
80°C. 
As can be observed from Table 1, the catalytic performance of 
the complexes is very different and, as expected, modification of the 
ancillary ligands have a dramatic effect on the catalytic properties. 
In particular the results obtained for 6 and 11 stand out among all 
the reported data. The cationic acetonitrile-solvated Rh-hydride 
complex [RhClH(CH3CN)3(IPr)]+ (11) reached excellent values of 
activity in the deuteration of β-vinyl protons of the styrene (TOF1/2 = 
3110 h-1), with a 92% of deuterium incorporation in less than 20 min 
(entry 8). This complex resulted to be the most active catalyst 
among all synthesized, being 10 times faster than the previously 
reported complex [RhClH(κ2-O,N-C9H6NO)(IPr)] (4) (entry 1). In 
 6
addition, is worthy of note that the value of 92% of β-deuteration 
attained with 11 approaches to the maximum theoretical value of β-
deuteration attainable under the reaction conditions (92.5%), thus 
reaching an deuteration efficiency of >99%.[23] However, this 
exceptional increase in catalytic activity is accompanied by a loss of 
selectivity as 10% of deuteration at the α-vinyl position was 
observed. The activity of a catalyst is highly important but, for 
practical applications, the selectivity is fundamental. In this respect, 
complex [RhClH(κ2-O,N-C9H6NO)(SIPr)] (6) is certainly the 
catalyst precursor with the best catalytic performance. In fact, as can 
be observed from Table 1 (entry 3), in addition to its excellent 
catalytic activity (TOF1/2 = 306 h-1) an outstandingly high selectivity 
values in the deuteration of the β-vinyl hydrogens (also in this case 
>99% of the maximum theoretical β-deuteration value) was 
achieved with deuterium incorporation at the α-vinyl position only 
at trace levels. For what concerns the other synthesized complexes, 
good results in terms of catalytic performance were obtained for 
complexes 5, 8, 12, 14 and 15 (entries 2, 5, 9, 11 and 12, 
respectively), with TOF1/2 values between 90 to 179 h-1, and good 
selectivity towards the β-vinyl deuterated olefin. On the other hand, 
complex 9 showed moderate activity at 80°C (entry 6) and 
complexes 7, 10, 13, and 16 were practically inactive even at 80°C 
(entries 4, 7, 10, 13, respectively). 
In order to analyze these results in more detail taking into 
account the different nature of catalyst precursors, it seem important 
to focus on the mechanism by which these catalysts operate. As 
previously proposed,[7j] the first step of the process is the exchange 
of the hydride ligand RhIII-H (a) by deuterium from the deuterated 
solvent (CD3OD) to generate a RhIII-D (b) species (Scheme 8).[24] 
Then, after coordination of the olefin to complex b to give an 
intermediate species with both ligands in cis disposition ,[25] the 
orientation of the η2-coordinated olefin determines the insertion 
pathway. A 1,2 insertion on the Rh-D bond give rise to the linear 
product c, whereas a 2,1 insertion provides the branched product e. 
At this point, rotation around the C1-C2 alkyl axis is essential in 
order to an effective H/D exchange (c → d; e → f).[26] Subsequent β-
H elimination in d produces α-deuteration whereas that in f give rise 
to the β-deuterated olefin. The critical step determining the 
selectivity is the rotation around the C1-C2 alkyl axis. In the case of 
c, the steric hindrance imposed by the ligands in the complex, 
restricts that rotation (and the formation of d) due to repulsion 
between the R group of the alkyl ligand and the substituents of the 
NHC, thus meaning that although a deuterium atom can enter the 
benzyl position the hydrogen atom cannot easily leave. On the 
contrary, in the case of complex e, the terminal methyl group can 
easily rotate to form complex f, from which the β-deuterated olefin 
is obtained after β-H elimination. 
 
Scheme 8. Mechanism of H/D exchange of olefins mediated by RhIII-H catalyst. 
The NHC ligand has a strong influence on the catalytic 
performance. The substitution of IPr for IMes in complex 5 (entry 2) 
produces a decrease both of the activity and selectivity. This is 
probably due to the lower electron-donor ability and bulkiness of 
IMes with respect to IPr.[15b,20]. Complex 6, bearing the ligand SIPr, 
is the more selective throughout the studied catalysts and the most 
active among those having the 8-quinolinolate ligand (entry 3). SIPr, 
the saturate analog of the IPr, is slightly more electron-donor and 
bulky,[15b] which can explain the observed improvement of the 
catalytic performance. In view of the trend that an increase of steric 
hindrance imparted by the NHC ligand results in a selectivity 
improvement, we envisage that the introduction of a bulky 
tetrahydropyrimidine-based NHC ligand (SPXyl) in complex 7 
could improve the catalytic outcome. However, rather surprisingly, 
complex 7 was completely ineffective (entry 4). It has been found 
that the hydride ligand of 7 does not undergo H/D exchange in 
CD3OD even at 80°C, thus explaining its inactivity as deuterium 
labeling catalyst. Most likely the high steric hindrance of the SPXyl 
ligand prevent hydride-CD3OD interaction. Thus, it becomes 
evident that bigger is better but without overshooting. 
The steric and electronic properties of the 8-quinolinolate ligand 
also have an impact on the catalytic performance. The modification 
of the bidentate O-N ligand lead to a complex with a lower 
electronic density (complex 8) and to another complex with more 
steric hindrance close to the metallic center (complex 9). Catalyst 8 
presents two chloro substituents in the quinolinolate skeleton that 
decrease the electron density on the metal center thus reducing the 
catalytic activity (entry 5), with results comparable to those obtained 
for the complex 5 (entry 2). The case for complex 9 bearing a 2-
methyl-8-quinolinolate ligand is slightly different. Catalyst 9 
showed no catalytic activity at room temperature, reaching only a 
moderate activity and selectivity at 80°C (entry 6). In this case, 
contrary to 7, the hydride ligand in 9 is smoothly deuterated by 
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CD3OD. Thus, most probably the steric hindrance imposed by the 
quinolinolate ligand should difficult olefin coordination.  
The charge of the complexes also influences the catalytic 
performance. In fact, the catalyst precursor [RhH(κ2-O,N-
C9H6NO)(IPr)(CH3CN)2](PF6) (10), the cationic derivative of 
complex 4 obtained by elimination of chlorido ligand, showed no 
catalytic activity at all (entry 7). In sharp contrast, the cationic 
chlorido complex [RhClH(CH3CN)3(IPr)]CF3SO3 (11) is the most 
active catalyst precursor among all synthesized (entry 8). This result 
suggests that the presence a chlorido ligand is essential for the 
activity of the catalyst. Most probably the role of chlorido ligand 
was the stabilization of key RhIII catalytic. In fact, it has been 
observed that complex 10 decomposed rapidly under the reaction 
conditions leading to an unidentified mixture of complexes unable 
to catalyze the H/D exchange of styrene. This chlorido effect can be 
appreciated also in the case of the complexes lacking a 8-
quinolinolate ligand bearing more labile acetonitrile ligands. The 
excellent catalytic activity of 11 could be also related to the 
presence of labile acetonitrile ligands that facilitates the olefin 
coordination and insertion processes. However, this effect also leads 
to a loss of the selectivity (10% α-deuteration). The presence of two 
chlorido ligands in the neutral complex [RhCl2H(CH3CN)2(IPr)] 
(12), resulted in a decrease of the catalytic activity (entry 9). Finally, 
the dicationic complex lacking a chloride ligand 
[RhH(CH3CN)4(IPr)](CF3SO3)2 (13) was totally inactive (entry 10). 
As shown in Scheme 8, the operative insertion-elimination 
mechanism for H/D exchange in olefins requires the participation of 
active hydride species. For this reason, ethyl complexes 14-16 
should be inactive. However, complex [RhCl(CH2CH3)(κ2-O,N-
C9H6NO)(IPr)] (14) is only slightly less active than the hydride 
counterpart 4 (entry 11). That fact can be explained assuming that 
such species could be in equilibrium with hydride-olefin species.[22]  
 
Scheme 9. Equilibrium between Rh-ethyl and Rh-H/ethylene species. 
As it could be expected, the catalytic performance of the 
acetonitrile complex 15 (entry 12) is identical to that of 14, since the 
dissociation of the labile acetonitrile ligand produces the same 
active species. Also, the dicationic catalyst precursor 
[Rh(CH2CH3)(IPr)(CH3CN)4](CF3SO3)2 (16), which does not 
contain a chlorido ligand, resulted to be completely inactive (entry 
13).  
Conclusions 
A series of new hydride-RhIII-NHC and ethyl-RhIII-NHC 
complexes containing different substituted quinolinolate or 
acetonitrile donor ligands have been synthesized and fully 
characterized. Both types of RhIII-NHC complexes have been used 
as catalysts for the H/D exchange of olefins using CD3OD as 
deuterium source. Most of these complexes resulted to be very 
active and selective in the vinylic-H/D exchange of styrene, without 
the concomitant deuteration of the aromatic region. Moreover, they 
were able to deuterate the vinylic-β-positions with very high 
selectivity. 
It has been observed that the NHC ligand play an important role 
in the catalytic activity and selectivity. In fact, along the series 
[RhClH(κ2-O,N-C9H6NO)(NHC)], and taking the IPr complex as a 
reference, the complex bearing a better electron-donor carbene, SIPr, 
resulted the most active catalyst with outstanding selectivity for the 
β-vinylic positions, while the introduction of a less electron-donor 
and less bulky carbene such as IMes decreased the catalytic activity 
and selectivity. On the other hand, complexes bearing carbenes with 
good electron-donor properties but with large steric hindrance, as 
the SPXyl, did not show any catalytic activity. The remaining 
involved ligands also played an important role in the catalytic 
proprieties. In fact, complexes without chlorido ligand are inactive, 
and the introduction of a 8-quinolinolate ligand with an electron-
withdrawing substituents or a bulky group near to the Rh, reduced or 
suppressed the catalytic activity, respectively. Replacement of the 
chelate quinolinolate ligand by weakly bonded acetonitrile ligands 
increased the catalytic activity but decreased the selectivity of the 
catalyst. In fact, the cationic complex [RhClH(CH3CN)3(IPr)]+ 
showed an excellent catalytic activity reaching the maximum 
attainable degree of β-vinylic deuteration in only 20 min. On the 
other hand, along the ethyl-RhIII-IPr series, complex 
[RhCl(CH2CH3)(8-quinolinolate)(IPr)] also showed a good catalytic 
activity which can be rationalized assuming an equilibrium with 
hydride-olefin species. In conclusion, this work represents an in-
depth study for developing improved catalytic systems by ligand 
modification which along with the understanding of the catalytic 
mechanism, allow for the design of better performing catalysts. 
Experimental Section 
General Information. All reactions were carried out with rigorous exclusion of air 
using Schlenk-tube techniques. Organic solvents were obtained oxygen- and water-free 
from a Solvent Purification System (Innovative Technologies), except for THF that was 
dried over sodium and distilled under argon prior to use. The starting materials [Rh(µ-
Cl)(η2-coe)2]2 (1),[27] [Rh(µ-Cl)(IPr)(η2-coe)]2 (2a),[16b] [Rh(µ-Cl)(IPr)(η2-CH2=CH2)]2 
(2b),[16e] [Rh(µ-OH)(IPr)(η2-coe)]2 (2-OH),[21] [Rh(µ-Cl)(IMes)(η2-coe)]2 (3),[16b] 
[RhClH(κ2-O,N-C9H6NO)(IPr)] (4),[7j] IPr,[18a] IMes,[18a] ICy,[18c] SPXyl,[18b] and 
SIPr,[18d] were prepared following the procedures described in the literature. 1H, 31P{1H}, 
19F and 13C{1H} NMR spectra were recorded on either a Varian Gemini 2000, a Bruker 
ARX 300 or a Bruker Avance 500 and 400 MHz instrument. Chemical shifts (expressed 
in parts per million) are referenced to residual solvent peaks (1H, 13C{1H}) or external 
H3PO4 (31P{1H}) or CFCl3 (19F). Coupling constants, J, are given in hertz. Spectral 
assignments were achieved by combination of 1H-1H COSY, 13C{1H}-APT and 1H-13C 
HSQC/HMBC experiments. C, H, and N analyses were carried out in a Perkin-Elmer 
2400 CHNS/O analyzer. 
Catalytic H/D Exchange. In a NMR tube 0.01mmol of catalyst were dissolved in 0.5 
mL of CD3OD and then the olefin (0.5 mmol) was added and the reaction course 
monitored by 1H-NMR spectroscopy. The H/D exchange was quantified on the basis of 
the decrease in the integral value of the olefin resonances compared to those of the 
internal standardhexamethyldisiloxane (2 µL, 10 µmol). The successful deuteration of 
the olefin was confirmed by 2H-NMR spectroscopy. 
Preparation of [RhClH(κ2-O,N-C8H6NO)(IMes)] (5). A yellow solution of 3 (300 mg, 
0.271 mmol) in toluene (10 mL) was treated with 8-hydroxyquinoline (79 mg, 0.542 
mmol) and stirred at room temperature for 45 min. The solution was concentrated to ca. 
1 mL and then n-hexane (3 mL) was added to induce the precipitation of an orange solid 
which was washed with hexane (3 x 3 mL) and dried in vacuo. Yield: 252 mg (79%). 
Anal. Calcd. for C30H31N3ClORh: C, 61.28; H, 5.31; N, 7.15. Found: C, 61.54; H, 5.39; 
N, 7.11. 1H NMR (400 MHz, tol-d8, 298 K): δ 8.92 (d, JH-H = 4.6, 1H, H2-Quin), 7.17 (d, 
JH-H = 8.1, 1H, H4-Quin), 7.14 (dd, JH-H = 7.8, 7.7, 1H, H6-Quin), 6.68 (br, 4H, HPh-IMes), 
7.04 (d, JH-H = 7.7, 1H, H7-Quin), 6.39 (s, 2H, =CHN), 6.48 (d, JH-H = 7.8, 1H, H5-Quin), 
6.29 (dd, JH-H = 8.1, 4.6, 1H, H3-Quin), 2.47, 2.44, and 1.90 (all s, 18H, MeIMes), -28.49 (d, 
1H, JRh-H = 46.0, H-Rh). 13C{1H}-APT NMR (100.6 MHz, tol-d8, 298 K): δ 177.5 (d, 
JC-Rh = 49.7, Rh-CIPr), 171.1 (s, C8-Quin), 146.5 (s, C2-Quin), 145.5 (s, C8a-Quin), 139.6, 137.8, 
and 137.5 (all s, Cq-IMes), 137.6 (s, CqN), 137.1 (s, C4-Quin), 130.9 (s, C4a-Quin), 129.9 and 
129.8 (both s, CHPh-IMes), 129.5 (s, C6-Quin), 123.4 (s, =CHN), 120.8 (s, C3-Quin), 114.4 (s, 
C7-Quin), 111.3 (s, C5-Quin), 21.3, 18.9, and 18.8 (all s, MeIMes).  
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Preparation of [RhClH(κ2-O,N-C8H6NO)(SIPr)] (6). A yellow suspension of 1 (300 
mg, 0.418 mmol) in THF (10 mL) was treated with SIPr (327 mg, 0.838 mmol) and 8-
hydroxyquinoline (121 mg, 0.836 mmol) and stirred at room temperature for 30 min. 
The resulting orange solution was evaporated to dryness, dissolved in 10 mL of toluene 
and filtered through a bed of celite. The filtrate was concentrated to ca. 1 mL and then 
n-hexane (3 mL) was added to induce the precipitation of an orange solid which was 
washed with hexane (3 x 3 mL) and dried in vacuo. Yield: 231 mg (73%). Anal. Calcd. 
for C36H45N3ClORh: C, 64.14; H, 6.73; N, 6.23. Found: C, 64.56; H, 6.85; N, 6.15. 1H 
NMR (300 MHz, C6D6, 298 K):δ 8.97 (d, JH-H = 4.3, 1H, H2-Quin), 7.19 (dd, JH-H = 7.7, 
7.4, 1H, H6-Quin), 7.12 (d, JH-H = 8.1, 1H, H4-Quin), 7.10 (m, 6H, HPh-SIPr), 7.07 (d, JH-H = 
7.4, 1H, H7-Quin), 6.50 (d, JH-H = 7.7, 1H, H5-Quin), 6.24 (dd, JH-H = 8.1, 4.3, 1H, H3-Quin), 
3.90 and 3.87 (both sept, JH-H = 6.6, 4H, CHMeSIPr), 3.83 (m, 4H, CH2-SIPr), 1.64, 1.62, 
1.25, and 1.22 (all d, JH-H = 6.6, 24H, CHMeSIPr), -28.61 (d, 1H, JRh-H = 47.3, H-Rh). 
13C{1H}-APT NMR (75.4 MHz, C6D6, 298 K): δ 208.2 (d, JC-Rh = 44.7, Rh-CSIPr), 170.9 
(s, C8-Quin), 148.9 (s, Cq-SIPr), 146.5 (s, C2-Quin), 145.2 (s, C8a-Quin), 137.2 (s, C4-Quin), 136.1 
(s, CqN), 130.8 (s, C4a-Quin), 130.3, 125.2, and 125.1 (s, CHPh-SIPr), 129.6 (s, C6-Quin), 
120.9 (s, C3-Quin), 114.3 (s, C7-Quin), 111.1 (s, C5-Quin), 54.4 (s, CH2-SIPr), 29.5 and 29.4 
(both s, CHMeSIPr), 27.1, 27.0, 24.6, and 24.5 (all s, CHMeSIPr).  
Preparation of [RhClH(κ2-O,N-C8H6NO)(SPXyl)] (7). The complex was prepared as 
described for 6 starting from 1 (300 mg, 0.418 mmol), SPXyl (245 mg, 0.836 mmol), 
and 8-hydroxyquinoline (121 mg, 0.836 mmol), and obtained as an orange solid. Yield: 
327 mg (68%). Anal. Calcd. for C29H31N3ClORh: C, 60.48; H, 5.43; N, 7.30. Found: C, 
60.86; H, 5.53; N, 6.95. 1H NMR (500 MHz, tol-d8, 298 K):δ 8.89 (dd, JH-H = 4.8, 1.3, 
1H, H2-Quin), 7.24 (dd, JH-H = 8.3, 1.3, 1H, H4-Quin), 7.21 (dd, JH-H = 7.9, 7.8, 1H, H6-Quin), 
6.9-6.6 (m, 6H, HPh-SPXyl), 7.05 (dd, JH-H = 7.8, 1.0, 1H, H7-Quin), 6.53 (dd, JH-H = 7.9, 1.0, 
1H, H5-Quin), 6.35 (dd, JH-H = 8.3, JH-H = 4.8, 1H, H3-Quin), 3.0-2.9 (m, 4H, CH2NSPXyl), 
2.64, 2.62, 2.55, and 2.56 (all s, 12H, Me6-Xyl), 1.76 and 1.65 (both m, 2H, CH2-SPXyl), -
27.94 (d, 1H, JRh-H = 44.4, H-Rh). 13C{1H}-APT NMR (100.6 MHz, tol-d8, 298 K): δ 
200.9 (d, JC-Rh= 44.5, Rh-CSPXyl), 170.6 (s, C8-Quin), 147.2 and 139.0 (both s, CqN), 146.2 
(s, C2-Quin), 145.1 (s, C8a-Quin), 137.0 (s, C4-Quin), 139.6, 139.4, 137.5, and 137.2 (all s, Cq-
SPXyl), 129.8, 129.5, 129.3. 129.2, 128.9, and 128.5 (s, CHPh-SPXyl), 130.9 (s, C4a-Quin), 
129.5 (s, C6-Quin), 120.8 (s, C3-Quin), 113.9 (s, C7-Quin), 110.7 (s, C5-Quin), 47.3 and 46.7 
(both s, CH2NSPXyl), 21.9 (s, CH2-SPXyl), 19.8, 19.6, 18.8, and 18.7 (all s, MeSPXyl)  
Preparation of [RhClH(κ2-O,N-C8H4NOCl2)(IPr)] (8). The complex was prepared as 
described for 5 starting from 2a (300 mg, 0.235 mmol) and 5,7-dichloro-8-
hydroxyquinoline (100 mg, 0.470 mmol), and isolated as an orange solid. Yield: 272 mg 
(78%). Anal. Calcd. for C36H41N3Cl3ORh: C, 58.35; H, 5.58; N, 5.67. Found: C, 58.74; 
H, 5.40; N, 5.59. 1H NMR (300 MHz, C6D6, 298 K): δ 8.85 (d, JH-H = 4.4, 1H, H2-Quin), 
7.65 (s, 1H, H6-Quin), 7.65 (d, JH-H = 8.1, 1H, H4-Quin), 7.2-7.0 (m, 6H, HPh-IPr), 6.75 (s, 2H, 
=CHN), 6.18 (dd, JH-H = 8.1, JH-H = 4.4, 1H, H3-Quin), 3.42 and 3.40 (both sept, JH-H = 6.8, 
4H, CHMeIPr), 1.58, 1.56, 1.16, and 1.15 (all d, JH-H = 6.8, 24H, CHMeIPr), -27.81 (d, 
1H, JRh-H = 43.6, H-Rh). 13C{1H}-APT NMR (75.4 MHz, C6D6, 298 K): δ 176.7 (d, JC-
Rh= 49.2, Rh-CIPr), 164.9 (s, C8-Quin), 147.6 and 147.5 (both s, Cq-IPr), 147.4 (s, C2-Quin), 
145.5 (s, C8a-Quin), 137.9 (s, CqN), 133.9 (s, C4-Quin), 130.8, 125.7, and 124.5 (s, CHPh-IPr), 
129.6 (s, C6-Quin), 125.1 (s, =CHN), 121.2 (s, C3-Quin), 117.6 (s, C7-Quin), 112.9 (s, C5-Quin), 
126.6 (s, C4a-Quin), 29.0 and 28.9 (both s, CHMeIPr), 26.3, 26.2, 23.6, and 23.4 (all s, 
CHMeIPr).  
Preparation of [RhClH(κ2-O,N-C8H5NOCH3)(IPr)] (9). A yellow solution of 2a (300 
mg, 0.235 mmol) in toluene (10 mL) was treated with 2-methyl-8-hydroxyquinoline (75 
mg, 0.470 mmol) and stirred at 80°C for 2 hours. The solution was concentrated to ca. 1 
mL and then n-hexane (3 mL) was added to induce the precipitation of an orange solid 
which was washed with hexane (3 x 3 mL) and dried in vacuo. Yield: 229 mg (71%). 
Anal. Calcd. for C37H45N3ClORh: C, 64.77; H, 6.61; N, 6.12. Found: C, 65.04; H, 6.93; 
N, 6.12. 1H NMR (300 MHz, C6D6, 298 K): δ 7.23 (dd, JH-H = 7.9, 7.8, 1H, H6-Quin), 7.17 
(d, JH-H = 8.4, 1H, H4-Quin), 7.2-7.0 (m, 6H, HPh-IPr), 7.08 (dd, JH-H = 7.9, 1.0, 1H, H7-Quin), 
6.75 (s, 2H, =CHN), 6.60 (dd, JH-H = 7.8, 1.0, 1H, H5-Quin), 6.15 (d, JH-H = 8.4, 1H, H3-
Quin), 3.57 and 3.51 (both br, 4H, CHMeIPr), 2.78 (s, 1H, CH3-Quin), 1.56, 1.54, 1.15, and 
1.14 (all d, JH-H = 6.8, 24H, CHMeIPr), -28.43 (d, 1H, JRh-H = 45.2, H-Rh). 13C{1H}-APT 
NMR (75.4 MHz, C6D6, 298 K): δ 175.7 (d, JC-Rh = 51.6, Rh-CIPr), 170.5 (s, C8-Quin), 
162.3 (s, C2-Quin), 148.1 and 148.0 (both s, Cq-IPr), 144.4 (s, C8a-Quin), 137.5 (s, C4-Quin), 
137.2 (s, CqN), 131.0, 124.8, and 124.7 (s, CHPh-IPr), 129.1 (s, C4a-Quin), 128.3 (s, C6-Quin), 
125.1 (s, =CHN), 124.4 (s, C3-Quin), 115.1 (s, C7-Quin), 111.4 (s, C5-Quin), 29.4 and 29.3 
(both s, CHMeIPr), 27.3 (s, CH3-Quin), 26.9, 26.8, 23.9, and 23.8 (all s, CHMeIPr).  
Preparation of [RhH(κ2-O,N-C8H6NO)(IPr)(CH3CN)2]PF6 (10). An orange solution 
of 4 (150 mg, 0.223 mmol) in CH3CN (5 mL) was treated with TlPF6 (78 mg, 0.223 
mmol) and stirred at room temperature for 15 min. The suspension was filtered through 
a celite bed. Then, the solvent was evaporated to dryness and the residue stirred with 
diethyl ether to give an orange solid which was washed with diethyl ether (3 x 2 mL) 
and dried in vacuo. Yield: 131 mg (68%). Anal. Calcd. for C40H49N5ORhPF6: C, 55.62; 
H, 5.72; N, 8.11. Found: C, 55.86; H, 5.88; N, 8.05.1H NMR (400 MHz, CD3CN, 298 
K): δ 8.40 (d, JH-H = 4.7, 1H, H2-Quin), 8.20 (d, JH-H = 8.4, 1H, H4-Quin), 7.54 (s, 2H, 
=CHN), 7.36 (dd, JH-H = 8.4, 4.7, 1H, H3-Quin), 7.24 (dd, JH-H = 8.1, 8.0, 1H, H6-Quin), 7.5-
7.3 (m, 6H, HPh-IPr), 6.87 (dd, JH-H = 8.1, 1.0, 1H, H5-Quin), 6.69 (dd, JH-H = 8.0, 1.0, 1H, 
H7-Quin), 2.85 and 2.84 (both sept, JH-H = 6.8, 4H, CHMeIPr), 1.30, 1.23, 1.19, and 1.17 
(all d, JH-H = 6.8, 24H, CHMeIPr), -17.52 (d, 1H, JRh-H = 21.1, H-Rh). 13C{1H}-APT 
NMR (100.6 MHz, CD3CN, 298 K): δ 171.3 (s, C8-Quin), 169.6 (br, Rh-CIPr), 148.1 and 
148.0 (both s, Cq-IPr), 146.8 (s, C2-Quin), 144.4 (s, C8a-Quin), 138.8 (s, C4-Quin), 138.3 (s, 
CqN), 131.7, 125.5, and 125.4 (s, CHPh-IPr), 131.4(s, C4a-Quin), 130.7 (s, C6-Quin), 127.4 (s, 
=CHN), 125.0 (s, C3-Quin), 115.3 (s, C7-Quin), 112.0 (s, C5-Quin), 29.7 and 29.6 (both s, 
CHMeIPr), 26.1, 26.0, 23.5, and 23.4 (all s, CHMeIPr). 13P NMR (121.5 MHz, CD3CN, 
298 K): δ -144.6 (sept, JP-F = 706.6, PF6) 
Preparation of [RhClH(CH3CN)3(IPr)]OTf (11). A yellow suspension of 2a (300 mg, 
0.270 mmol) in CH3CN (10 mL) at 253 K was treated with HOTf (48 µL, 0.540 mmol) 
and stirred at low temperature for 15 min. The resulting solution was concentrated to ca. 
1 mL and then, the addition of cold diethyl ether (253 K) induced the precipitation of a 
white solid which was washed with diethyl ether (3 x 4 mL) and dried in vacuo. Yield: 
315 mg (73%). Anal. Calcd. for C34H46N5F3ClO3SRh: C, 51.03; H, 5.79; N, 8.75; S, 
4.00. Found: C, 51.30; H, 6.04; N, 8.43; S, 4.12. 1H NMR (400 MHz, CD3CN, 298 K): 
δ 7.59 (t, JH-H = 7.8, 2H, Hp-Ph-IPr), 7.46 (d, JH-H = 7.8, 4H, Hm-Ph-IPr), 7.44 (s, 2H, =CHN), 
2.69 and 2.68 (both sept, JH-H = 6.8, 4H, CHMeIPr), 1.30, 1.29, 1.11, and 1.08 (all d, JH-H 
= 6.8, 24H, CHMeIPr), -17.05 (d, JRh-H = 8.4, 1H, H-Rh). 13C{1H}-APT NMR (100.6 
MHz, CD3CN, 298 K): δ 161.2 (d, JC-Rh = 49.1, Rh-CIPr), 147.2 (both s, Cq-IPr), 137.4 (s, 
CqN), 131.7 (s, Cp-Ph-IPr), 127.5 (s, =CHN), 125.0 (s, Cm-Ph-IPr), 122.1 (q, JC-F = 321.2, 
CF3), 29.5 and 29.4 (both s, CHMeIPr), 26.2 25.9, 23.0, and 22.3 (all s, CHMeIPr). 19F 
NMR (376 MHz, CD3CN, 298 K): δ -78.2 (s, OTf).  
Preparation of [RhCl2H(CH3CN)2(IPr)] (12). The complex was prepared as described 
for 11 starting from 2a (300 mg, 0.270 mmol) and HCl 37% (water solution) (44 µL, 
0.540 mmol). A white solid was obtained. Yield: 223 mg (64%). Anal. Calcd. for 
C31H43N4Cl2Rh: C, 57.68; H, 6.71; N, 8.68. Found: C, 58.06; H, 6.88; N, 8.61. 1H NMR 
(400 MHz, CD3CN, 253 K): δ 7.52 (m, 2H, Hp-Ph-IPr), 7.39 (m, 4H, Hm-Ph-IPr), 7.26 and 
7.25 (br, 2H, =CHN), 3.14 and 2.85 (both sept, JH-H = 6.6, 4H, CHMeIPr), 1.27, 1.26, 
1.05, and 1.02 (all d, JH-H = 6.6, 24H, CHMeIPr), -18.63 (d, JRh-H = 8.5, 1H, H-Rh). 
13C{1H}-APT NMR (100.6 MHz, CD3CN, 253 K): δ 167.0 (d, JC-Rh = 49.9, Rh-CIPr), 
147.6 and 147.3 (both s, Cq-IPr), 138.1 and 137.0 (both s, CqN), 130.4 and 129.7 (both s, 
Cp-Ph-IPr), 126.7 and 125.5 (both s, =CHN), 123.7 and 125.5 (both s, Cm-Ph-IPr), 28.3 and 
28.2 (both s, CHMeIPr), 25.3, 25.2, 22.4, and 22.3 (all s, CHMeIPr).  
Preparation of [RhH(CH3CN)4(IPr)](OTf)2 (13). A yellow suspension of 2-OH (300 
mg, 0.242 mmol) in CH3CN (10 mL) at -20°C was treated with HOTf (175 µL, 1.455 
mmol) and stirred at low temperature for 15 min. The resulting pale yellow solution was 
concentrated to ca. 1 mL and then, the addition of cold diethyl ether (-20°C) induced the 
precipitation of a white solid which was washed with diethyl ether (3 x 4 mL) and dried 
in vacuo. Yield: 508 mg (91%). Anal. Calcd. for C37H49N6F6O6S2Rh: C, 46.54; H, 5.17; 
N, 8.80; S, 6.72 Found: C, 46.19; H, 4.98; N, 8.72; S, 6.92.1H NMR (400 MHz, CD3CN, 
298 K): δ 7.68 (t, JH-H = 7.5, 2H, Hp-Ph-IPr), 7.52 (t, JH-H = 7.5, 4H, Hm-Ph-IPr), 7.65 (s, 2H, 
=CHN), 2.38 (sept, JH-H = 6.8, 4H, CHMeIPr), 1.32 and 1.14 (both d, JH-H = 6.8, 24H, 
CHMeIPr), -15.38 (d, JRh-H = 7.3, 1H, H-Rh). 13C{1H}-APT NMR (100.6 MHz, CD3CN, 
298 K): δ 153.8 (d, JC-Rh = 46.7, Rh-CIPr), 147.1 (s, Cq), 136.4 (s, CqN), 132.7 (s, Cp-Ph-
IPr), 128.9 (s, =CHN), 125.6 (s, Cm-Ph-IPr), 122.0 (q, JC-F = 321.0, CF3), 29.8 (s, CHMeIPr), 
26.0 and 22.7 (both s, CHMeIPr). 19F NMR (376 MHz, CD3CN, 298 K): δ -79.2 (s, OTf).  
Preparation of [RhCl(CH2CH3)(κ2-O,N-C8H6NO)(IPr)] (14). The complex was 
prepared as described for 5 starting from 2b (300 mg, 0.270 mmol) and 8-
hydroxyquinoline (78 mg, 0.540 mmol), and obtained as an orange solid. Yield: 325 mg 
(86%). Anal. Calcd. for C38H47N3ClORh: C, 65.19; H, 6.77; N, 6.00. Found: C, 65.56; 
H, 6.32; N, 6.24. 1H NMR (400 MHz, C6D6, 298 K): δ 9.17 (d, JH-H = 4.7, 1H, H2-Quin), 
7.31 (d, JH-H = 8.5, 1H, H4-Quin), 7.29 (dd, JH-H = 7.9, 7.8, 1H, H6-Quin), 7.06 (m, 6H, HPh-
IPr), 7.13 (dd, JH-H = 7.8, 1.0, 1H, H7-Quin), 6.71 (s, 2H, =CHN), 6.61 (dd, JH-H = 7.9, 1.0 
1H, H5-Quin), 6.39 (dd, JH-H = 8.5, 4.7, 1H, H3-Quin), 3.62 and 3.09 (both ddq, JH-H = 7.3, 
7.1, JRh-H = 3.2, 2H, CH2-Ethyl), 3.50 and 3.49 (both sept, JH-H = 6.6, 4H, CHMeIPr), 1.65, 
1.41, 1.15, and 1.08 (all d, JH-H = 6.6, 24H, CHMeIPr), -0.27 (dvt, JRh-H = 1.5, N = 14.6, 
3H, CH3-Ethyl). 13C{1H}-APT NMR (100.6 MHz, C6D6, 298 K): δ 174.5 (d, JC-Rh = 51.8, 
Rh-CIPr), 171.5 (s, C8-Quin), 147.8 and 147.5 (both s, Cq-IPr), 146.6 (s, C2-Quin), 145.2 (s, 
C8a-Quin), 137.1 (s, C4-Quin), 136.2 (s, CqN), 131.0 (s, C4a-Quin), 130.9, 124.5, and 124.2 (all 
s, CHPh-IPr), 129.9 (s, C6-Quin), 125.7 (s, =CHN), 120.1 (s, C3-Quin), 115.1 (s, C7-Quin), 110.8 
(s, C5-Quin), 29.5 and 29.4 (both s, CHMeIPr), 27.1, 26.8, 23.6, and 23.5 (all s, CHMeIPr), 
21.0 (d, JRh-C = 28.4, CH2-Ethyl), 20.6 (s, CH3-Ethyl).  
Preparation of [RhCl(CH2CH3)(κ2-O,N-C8H6NO)(IPr)(CH3CN)] (15). An orange 
solution of 14 (100 mg, 0.143 mmol) in a 1:1 toluene/CH3CN mixture (5 mL) was 
stirred at room temperature for 30 minutes. The solvent was evaporated to dryness and 
subsequent addition of hexane induced the precipitation of an orange solid which was 
washed with hexane (3 x 2 mL) and dried in vacuo. Yield: 84 mg (80%). Anal. Calcd. 
for C40H50N4ClORh: C, 64.33; H, 6.45; N, 7.25. Found: C, 64.82; H, 6.80; N, 7.56. 1H 
NMR (400 MHz, C6D6/CD3CN 4:1, 298 K): δ 9.08 (d, JH-H = 4.2, 1H, H2-Quin), 7.76 (d, 
JH-H = 8.1, 1H, H4-Quin), 7.32 (s, 2H, =CHN), 7.30 (dd, JH-H = 7.9, 7.8, 1H, H6-Quin), 7.2-
7.1 (m, 6H, HPh-IPr), 7.04 (d, JH-H = 7.9, 1H, H7-Quin), 6.90 (dd, JH-H = 8.1, 4.2, 1H, H3-
Quin), 6.78 (d, JH-H = 7.8, 1H, H5-Quin), 3.35 and 2.98 (both m, 2H, CH2-Ethyl) 3.44 (br, 4H, 
CHMeIPr), 1.60, 1.34, 1.24, and 1.16 (all d, JH-H = 6.5, 24H, CHMeIPr), 1.43 (s, CH3CN), 
-0.44 (dvt, JRh-H = 1.5, N = 14.0, 3H, CH3-Ethyl). 13C{1H}-APT NMR (100.6 MHz, 
C6D6/CD3CN 4:1, 298 K): δ 172.4 (d, JC-Rh = 50.2, Rh-CIPr), 170.9 (s, C8-Quin), 147.5 and 
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147.1 (both s, Cq-IPr), 145.9 (s, C2-Quin), 144.6 (s, C8a-Quin), 137.1 (s, C4-Quin), 135.8 (s, 
CqN), 130.6 (s, C4a-Quin), 130.5, 124.1, and 123.7 (all s, CHPh-IPr), 129.6 (s, C6-Quin), 126.0 
(s, =CHN), 121.0 (s, C3-Quin), 116.9 (s, CH3CN), 114.7 (s, C7-Quin), 110.4 (s, C5-Quin), 
29.1 and 29.1 (both s, CHMeIPr), 26.4, 26.1, 23.0, and 22.9 (all s, CHMeIPr), 20.0 (d, JRh-
C = 28.5, CH2-Ethyl), 19.9 (s, CH3-Ethyl), 0.28 (s, CH3CN). 
Preparation of [Rh(C2H5)(CH3CN)3(IPr)](OTf)2(16). A yellow suspension of 3 (300 
mg, 0.270 mmol) in CH3CN (10 mL) at -20°C was treated with trifluoromethansulfonic 
acid (96 µL, 1.080 mmol) and stirred at low temperature for 15 min. The resulting pale 
yellow solution was concentrated to ca. 1 mL and then, the addition of cold diethyl ether 
(-20°C) induced the precipitation of a white solid which was washed with diethyl ether 
(3 x 4 mL) and dried in vacuo. Yield: 417 mg (79%). Anal. Calcd. for 
C39H53N6F6O6S2Rh: C, 47.66; H, 5.44; N, 8.55; S, 6.52. Found: C, 47.99; H, 5.51; N, 
8.60; S, 6.75. 1H NMR (400 MHz, CD3CN, 298 K): δ 7.56 (t, JH-H = 7.7, 2H, Hp-Ph-IPr), 
7.46 (t, JH-H = 7.7, 4H, Hm-Ph-IPr), 7.33 (s, 2H, =CHN), 2.76 (dq, JRh-H = 2.2, JH-H = 7.4, 
2H, CH2-Ethyl), 2.67 (sept, JH-H = 6.8, 4H, CHMeIPr), 1.40 and 1.13 (both d, JH-H = 6.5, 
24H, CHMeIPr), 0.95 (t, JH-H = 7.4, 3H, CH3-Ethyl). 13C{1H}-APT NMR (100.6 MHz, 
CD3CN, 298 K): δ 150.3 (d, JC-Rh = 52.2, Rh-CIPr),147.2 (both s, Cq-IPr), 137.3 (s, CqN), 
133.1 (s, Cp-Ph-IPr), 129.0 (s, =CHN), 125.6 (s, Cm-Ph-IPr), 122.1 (q, JC-F = 321.2, CF3), 
29.9 (s, CHMeIPr), 26.0 and 23.0 (both s, CHMeIPr), 19.8 (s, CH3-Ethyl), 18.4 (d, JRh-C = 17.6, 
CH2-Ethyl). 19F NMR (376 MHz, CD3CN, 298 K): δ -78.2 (s, OTf). 
Crystal structure determination for complexes 4 and 16: X-ray diffraction data were 
collected at 100(2) K on a Bruker SMART APEX CCD (complex 16) and on a Bruker 
APEX II (complex 4) area detector diffractometers with graphite monochromated MoKα 
radiation (λ=0.71073 Å) by using narrow ω rotations (0.3º). Intensities were integrated 
and corrected for absorption effects with SMART,[28] SAINT+,[29] and SABABS[30] 
programs, included in APEX 2 package. The structures were solved by direct methods 
with SHELXS-97,[31] and refined by full-matrix least squares on F2 with SHELXL-
97.[32] Hydrogen atoms for both structures were included in calculated positions and 
refined with positional and displacement riding parameters. Particular details 
concerning the presence of solvent or static disorder are listed below. 
Crystal data for complex 4: C36H43ClN3ORh · C7H8; M = 764.23; orange prism; 0.167 
× 0.136 × 0.130 mm3; monoclinic; P21/n; a = 13.1379(10), b = 13.8002(11), c = 
20.7115(16)Å; β = 94.5440(10)º; Z = 4; V = 3743.3(5) Å3; ρcalcd = 1.356 gcm-3; µ = 
0.565 mm-1, min. and max. transmission factors: 0.912 and 0.930; 2θmax = 61.26; 26635 
reflections collected, 9828 unique [Rint = 0.0501]; number of data/restraints/parameters: 
9828/1/455; final GoF: 0.984, R1 = 0.0395 [6576 reflections, I>2σ(I)], ωR2 = 0.0906 for 
all data; largest difference peak: 0.611 eÅ3. A solvent toluene molecule has been 
included in the crystal structure. 
Crystal data for complex 16: C39H53F6N6O6RhS2 ·  CH2Cl2; M = 1067.83; colourless 
block; 0.162 × 0.070 × 0.057 mm3; triclinic; P-1; a = 12.134(7), b = 12.587(7), c = 
16.471(9)Å; α = 87.112(10), β = 78.900(9), γ = 83.677(10)º; Z = 2; V = 2452(2)Å3; 
ρcalcd = 1.446 gcm-3; µ = 0.614 mm-1, min. and max. transmission factors: 0.907 and 
0.956; 2θmax = 50.00; 24575 reflections collected, 8587 unique [Rint = 0.1047]; number 
of data/restraints/parameters: 8587/0/577; final GoF: 1.074, R1 = 0.0851 [5841 
reflections, I>2σ(I)], ωR2 = 0.1863 for all data; largest difference peak: 1.162 eÅ3. 
Fluorine atoms of the triflate anions showed high thermal parameters; static disorder 
was included for one of the anions. A solvent dichloromethane molecule was also 
observed in the crystal structure; both chlorine atoms were also included in a disordered 
model with complementary occupancy factors (0.674/0.326(19). All the relevant highest 
residual density peaks have found close to the metal atom, with no chemical sense. 
CCDC-989941 (4) and CCDC-989942 contain the supplementary crystallographic data 
for this paper. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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